Oncology

Looking Ahead to ESMO 2026: Supporting the Next Generation of Oncology Innovation

As ESMO 2026 approaches, oncology remains one of the most dynamic areas of drug development. From precision medicine and antibody-drug conjugates to radiopharmaceuticals and AI-driven…

How Assessment Aids Can Help You Get Your Oncology Product Approved Faster

A guide for applicants who want to participate in the voluntary program developed by the FDA’s Oncology Center of Excellence Are you looking to…